News

Press Release: Indica Labs achieves CE-IVD certification for AI-based Prostate Cancer Detection and Gleason Grading Tool

ALBUQUERQUE, NM – May 24, 2022 – Indica Labs, the leading provider of computational pathology software and services, is excited to announce a CE-IVD Mark for HALO Prostate AI, a deep learning-based screening tool designed to assist pathologists in identifying and grading prostate cancer in core needle biopsies.

Press Release: Indica Labs achieves CE-IVD certification for AI-based Prostate Cancer Detection and Gleason Grading Tool Read More »

Press Release: Lunaphore and Indica Labs announce partnership to provide complete technology solution for spatial biology and image analysis

LAUSANNE, Switzerland and ALBUQUERQUE, N.M. – May 12, 2022 – 5 pm (CET) | 9 am MDT – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Indica Labs, a leading provider of computational pathology software and services, today announced a partnership to co-market an end-to-end solution that combines Lunaphore’s flagship COMET™ spatial biology platform and Indica’s HALO® and HALO AI digital pathology image analysis software.

Press Release: Lunaphore and Indica Labs announce partnership to provide complete technology solution for spatial biology and image analysis Read More »

Maximizing use of HALO® and HALO AI for a comprehensive image analysis for HUMAN Brain FFPE Tissue samples in Alzheimer’s Disease

25 May 2022 | In this 60-min webinar, Learn how HALO and HALO AI are advancing neuropathology research at the UW Medicine Biorepository and Integrated Research (BRaIN) laboratory

Maximizing use of HALO® and HALO AI for a comprehensive image analysis for HUMAN Brain FFPE Tissue samples in Alzheimer’s Disease Read More »

Scroll to Top